TTF-1 Expression in Pulmonary Adenocarcinomas
暂无分享,去创建一个
[1] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] C. di Loreto,et al. TTF-1 gene expression in human lung tumours. , 1996, European journal of cancer.
[3] P. Chu,et al. Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases , 2000, Modern Pathology.
[4] L. Lim,et al. Thyroid transcription factor-1, hepatocyte nuclear factor-3beta, surfactant protein B, C, and Clara cell secretory protein in developing mouse lung. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[5] E. Schaafsma,et al. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. , 1990, The American journal of pathology.
[6] Dietel,et al. Thyroid transcription factor‐1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B , 2000, Histopathology.
[7] Robert K. Davis,et al. The myoD gene family: nodal point during specification of the muscle cell lineage. , 1991, Science.
[8] Rochelle L. Garcia,et al. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[9] Y. Yatabe,et al. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. , 1998, Cancer research.
[10] R. Lloyd,et al. Thyroid Transcription Factor-1 Distinguishes Metastatic Pulmonary From Well-Differentiated Neuroendocrine Tumors of Other Sites , 2001, The American journal of surgical pathology.
[11] Y. Shimosato. [Histological Typing of Lung and Pleural Tumors (3rd edition, 1999): Malignant epithelial tumors]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.
[12] G. Pelosi,et al. Immunoreactivity for Thyroid Transcription Factor-1 in Stage I Non–Small Cell Carcinomas of the Lung , 2001, The American journal of surgical pathology.
[13] C. I. Smith,et al. Correlation of expression of transcription factor C/EBP alpha and surfactant protein genes in lung cells. , 1995, The American journal of physiology.
[14] Y. Yatabe,et al. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] Y. Yatabe,et al. p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas. , 1998, Cancer research.
[16] J. Whitsett,et al. Lung Cell-specific Expression of the Murine Surfactant Protein A (SP-A) Gene Is Mediated by Interactions between the SP-A Promoter and Thyroid Transcription Factor-1 (*) , 1995, The Journal of Biological Chemistry.
[17] J. Whitsett,et al. Expression of thyroid transcription factor-1(TTF-1) in fetal and neonatal human lung. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[18] Xin Li,et al. Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas. , 2000, Human pathology.
[19] D. Botstein,et al. Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] C. Bingle,et al. The lung enriched transcription factor TTF-1 and the ubiquitously expressed proteins Sp1 and Sp3 interact with elements located in the minimal promoter of the rat Clara cell secretory protein gene. , 1996, The Biochemical journal.
[21] J. Whitsett,et al. Transcriptional Control in the Developing Lung , 1997 .
[22] R. Lauro,et al. The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis , 1994, Molecular and cellular biology.
[23] F. Puglisi,et al. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[24] W. Travis,et al. Alveolar adenoma: a histochemical, immunohistochemical, and ultrastructural analysis of 17 cases. , 1999, Human pathology.
[25] Y. Nikiforov,et al. Thyroid Transcription Factor-1, Thyroglobulin, Cytokeratin 7, and Cytokeratin 20 in Thyroid Neoplasms , 2000, Applied immunohistochemistry & molecular morphology : AIMM.
[26] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[27] F. Puglisi,et al. Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma. , 1997, Journal of clinical pathology.
[28] J. Rosai,et al. Cytokeratin-positive malignant tumors with reticulum cell morphology: a subtype of fibroblastic reticulum cell neoplasm? , 2000, The American journal of surgical pathology.
[29] B. Westermark,et al. The molecular biology of the human anaplastic thyroid carcinoma cell. , 1991, Thyroidology.
[30] J. Whitsett,et al. Upstream Enhancer Activity in the Human Surfactant Protein B Gene Is Mediated by Thyroid Transcription Factor 1 (*) , 1995, The Journal of Biological Chemistry.
[31] S. E. Kelly,et al. Transcription of the Lung-specific Surfactant Protein C Gene Is Mediated by Thyroid Transcription Factor 1 (*) , 1996, The Journal of Biological Chemistry.
[32] Y. Yatabe,et al. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[33] P. Minoo,et al. Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(-/-) mouse embryos. , 1999, Developmental biology.
[34] N. Ordóñez. Value of Thyroid Transcription Factor-1 Immunostaining in Distinguishing Small Cell Lung Carcinomas From Other Small Cell Carcinomas , 2000, The American journal of surgical pathology.
[35] R. Ueda,et al. Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] C. Mendelson,et al. Role of transcription factors in fetal lung development and surfactant protein gene expression. , 2000, Annual review of physiology.
[37] J. Minna,et al. Molecular genetics of small cell lung carcinoma. , 2001, Seminars in oncology.
[38] Dietel,et al. Expression of thyroid transcription factor‐1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites , 2000, Histopathology.
[39] V. Venkatesh,et al. Characterization of the promoter of human pulmonary surfactant protein B gene. , 1995, The American journal of physiology.
[40] N. Ordóñez,et al. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. , 2000, Advances in anatomic pathology.
[41] R. Katoh,et al. Thyroid Transcription Factor-1 in Normal, Hyperplastic, and Neoplastic Follicular Thyroid Cells Examined by Immunohistochemistry and Nonradioactive In Situ Hybridization , 2000, Modern Pathology.
[42] W. Travis,et al. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. , 2000, The American journal of surgical pathology.
[43] M. Miettinen,et al. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[44] J. Whitsett,et al. Transcriptional control in the developing lung. The Parker B. Francis lectureship. , 1997, Chest.
[45] R. Lauro,et al. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. , 1991, Development.
[46] C H Fox,et al. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. , 1996, Genes & development.
[47] S. Feinstein,et al. Transcriptional activation and protein binding by two regions of the rat surfactant protein A promoter. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[48] J. Chan,et al. Pulmonary Sclerosing Hemangioma Consistently Expresses Thyroid Transcription Factor-1 (TTF-1): A New Clue to Its Histogenesis , 2000, The American journal of surgical pathology.
[49] J. Minna,et al. The biology of non-small cell lung cancer. , 1983, Seminars in oncology.